All relevant data are within the manuscript and its Supporting Information files.

Introduction {#sec001}
============

Genetically encoded Fluorescent Proteins (FPs) have advanced basic and translational biology immensely. Starting with the cloning of the *Aequorea victoria* green FP\[[@pone.0219886.ref001]\], a massive and continual effort to expand the number of available FPs with a different physical and spectral properties began. Currently, there is an enormous variety of FPs at all parts of the visible spectrum, and even some parts of the ultraviolet and infrared spectrums. These new proteins were either cloned from other organisms\[[@pone.0219886.ref002]--[@pone.0219886.ref004]\], or developed through evolution of already identified FPs\[[@pone.0219886.ref004]--[@pone.0219886.ref011]\]. This ever expanding catalog of FPs has been reviewed by others\[[@pone.0219886.ref012]--[@pone.0219886.ref014]\], and new efforts and archives have been created to organize this information, such as the FPbase database\[[@pone.0219886.ref015]\].

As the catalogue of FPs has expanded, so have the potential uses. Of particular note is the use of FPs as biosensors which can measure signaling events, cell metabolites, pH, voltage and more\[[@pone.0219886.ref016]\]. Many of these biosensors employ Förster Resonance Energy Transfer (FRET) as part of their reporting mechanism, producing a change in acceptor emission upon donor excitation when the quantity of interest changes. FRET is also orientation and distance dependent\[[@pone.0219886.ref017]\], meaning that the magnitude of energy transfer (described as the FRET efficiency) can be used to study either the steady state or dynamic changes in protein interactions. Much of the work utilizing FPs for FRET has been done using Cyan/Yellow FP pairs due to their brightness, but these proteins suffer from large overlaps in their emission spectra making interpretation of results unnecessarily challenging, among other complicating factors. Green/Red FP pairs offer greater separation of their emission spectra while maintaining the high degree of spectral overlap between donor emission and acceptor absorption that allows for efficient energy transfer. Green/Red FPs also offer greater Förster radii than most Cyan/Yellow protein pairs, enabling FRET over longer distances. Being able to detect FRET over larger distances often leads to greater dynamic range and sensitivity. Additionally, cellular toxicity to blue light has been well documented in a variety of systems\[[@pone.0219886.ref018]--[@pone.0219886.ref022]\], emphasizing the need for better green and red shifted FRET pairs. Historically, Green/Red FRET has been limited by unfavorable fluorescent properties of the red protein\[[@pone.0219886.ref023]--[@pone.0219886.ref026]\], but several recently developed monomeric red fluorescent proteins are reported to have improved absorption, brightness, and stability indicating they may act as high quality FRET acceptors for green FPs.

It is the aim of this study to characterize these recently released red FPs as FRET acceptors in hopes of helping aid a more general adoption of Green/Red FRET. Here, we investigate the ability of next generation red FPs, mRuby3 and mScarlet-I as well as mCherry to act as a FRET acceptor for the green-yellow FP donor mNeonGreen. mRuby3\[[@pone.0219886.ref010]\] is the newest iteration of the Ruby series of red FPs\[[@pone.0219886.ref008], [@pone.0219886.ref009]\] originally developed from eqFP611\[[@pone.0219886.ref003]\]. The mScarlet series of red FPs\[[@pone.0219886.ref011]\] was developed from a synthetic gene template based off several naturally occurring red FPs. Three monomeric red FPs were evolved from this strategy, the bright variant mScarlet, the fast maturing variant mScarlet-I, and the fast lifetime variant mScarlet-H. For this study, we use mScarlet-I due to its fast maturation time, as slower maturation is less ideal for fusion proteins studies. mCherry\[[@pone.0219886.ref006]\], a commonly used monomeric red FP developed from DsRed\[[@pone.0219886.ref002]\], is included in this study to act as a standard. For the donor molecule, we chose mNeonGreen\[[@pone.0219886.ref004]\], an incredibly bright and stable green-yellow FP derived from the monomerization of the tetrameric yellow fluorescent protein LanYFP\[[@pone.0219886.ref004]\].

Materials and methods {#sec002}
=====================

Cell culture and transfection {#sec003}
-----------------------------

HEK293A cells (ATCC; Manassas, VA) were maintained in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 1X GlutaMAX^TM^, 100 units/mL penicillium, 100 μg/mL streptomycin (ThermoFisher Scientific; Waltham, MA), and 10% heat-inactivated fetal bovine serum (Atlas Biologicals; Fort Collins, CO). To induce expression of fluorescent proteins, cells were transiently transfected using polyethyenimine (PEI) transfection. For all transfections the indicated amounts of DNA and PEI where mixed together in DMEM containing no supplements for 30 minutes before addition to cells at the indicated time point. For FLIM experiments, cells were plated on number 1 cover slips (Warner Instruments; Hamden, CT) in 12-well plates (Nest Scientific USA; Rahway, NJ) 48 hours prior to experiments. Cells were then transfected 24 hours before experiments began using 0.6 μg of cDNA for the indicated construct and 1.6 μg of PEI in 1 mL of media. For confocal experiments, cells were plated in 35 mm plastic culture dishes (Corning; Corning, NY) 48--72 hours prior to experiments, followed by transfection with 1 μg of cDNA using 2.4 μg of PEI in 2 mL of media 24--36 hours before imaging began. For spectral FRET and immunoblotting experiments, cells were plated in 10 cm plastic culture dishes and allowed to grow to 70% confluency. Cells were then transfected with 4 μg of cDNA using 7.8 μg of PEI 24 hours before experiments started.

Plasmids and cloning {#sec004}
--------------------

All constructs used in this manuscript are derived from the pKanCMV-mClover3-mRuby3 plasmid (Plasmid \#74252) available on [Addgene.org](http://Addgene.org) (Addgene; Watertown, MA). NG-mRuby3 was created by removing mClover3 and all but the last 5 amino acids of the linker from pKanCMV-mClover3-mRuby3 by inverse PCR, and the full mNeonGreen coding sequence was inserted in its place using In-Fusion cloning (Takara Bio; Mountain View, CA). NG-mScarlet-I, NG-mScarlet, and NG-mCherry were created by deleting mRuby3 from NG-mRuby3 by inverse PCR and insertion of either mScarlet-I, mScarlet, or mCherry using In-Fusion cloning (Takara Bio). NG-Stop was created using the same inverse PCR product as NG-mScarlet-I and NG-mCherry via blunt end ligation using NEBs KLD Mix (New England Biolabs; Ipswich, MA). NG-P2A-mRuby3 was derived from the NG-mRuby3 using inverse PCR and blunt end ligation to insert the P2A sequence between the linker and mRuby3. The mRuby3-GGSGG-NG construct was made using a multi-fragment In-Fusion reaction using mRuby3 and mNeonGreen PCR products where the GGSGG linker was appended to the 3' end of mRuby3 and the 5' end of the mNeonGreen product via PCR. mClover3-Stop was made by deleting mRuby3 from the pKanCMV-mClover3-mRuby3 vector by inverse PCR and subsequent blunt end ligation. The amino acid sequences for all constructs described here is available in [S1 Table](#pone.0219886.s008){ref-type="supplementary-material"}. The mNeonGreen gene was obtained from the pmNeonGreen-NT plasmid (Allele Biotechnology; San Diego, CA), the mScarlet-I gene was obtained from the Lck-mScarlet-I plasmid (Addgene, plasmid \#98821), and the mCherry gene was obtained from the pmCherry-N1 plasmid (Takara Bio). Reaction products were transformed, screened, and amplified in XL10-Gold Ultracompetent *E*. *coli* cells (Agilent Technologies; Santa Clara, CA). Plasmid were isolated using an E.Z.N.A Plasmid MiniPrep Kit (Omega Bio-teck; Norcross, GA) or a ZymoPure II Plasmid Midiprep Kit (Zymo Research; Irvine, CA) per manufactures recommendations. All constructs were verified by sanger sequencing (Eurofins Genomics; Louisville, KY) and stored at a concentration of 1μg/μL in a -20°C freezer. All plasmids and constructs generated for this manuscript are freely available upon request.

Spectral FRET {#sec005}
-------------

For spectral FRET experiments, cells were used 24--36 hours post transfection. A single 10 cm dish of cells expressing the construct of interest were washed with imaging buffer (136 mM NaCl, 560 μM MgCl~2~, 4.7 mM KCl, 1 mM Na~2~HPO~4~, 1.2 mM CaCl~2~, 10 mM HEPES, 5.5 mM Glucose) several times and pelleted. Cell pellets were then resuspended in 500 μL of imaging buffer and transferred to disposable acrylate cuvettes (Spectrocell Inc; Oreland, PA). Emission scans were collected from 490--750 nm using a 470 nm excitation wavelength using a Cary Eclipse Fluorescence Spectrophotometer (Agilent Technologies). Cell were resuspended by vigorous pipetting immediately prior to scans. Data was collected in the Cary Eclipse Scan Application software package (Agilent Technologies) and exported to Microsoft Excel (Microsoft Corporation) for analysis. To estimate FRET efficiency from emission scans, linear unmixing was performed in Igor Pro (WaveMetrics Inc; Lake Oswego OR) using donor only and acceptor only emission scans to determine the contributions of donor and acceptor. Due to the high level of consistency between the NG-Stop and reported spectrum for purified mNeonGreen ([S1 Fig](#pone.0219886.s001){ref-type="supplementary-material"}), the purified mNeonGreen spectrum was used as the donor only scan for linear unmixing. For each of the acceptors, custom acceptor only scans were created based on experimentally collected data and their reported purified spectrum (as discussed in [S1 Fig](#pone.0219886.s001){ref-type="supplementary-material"}). All raw scans used for spectral FRET are available in [S1 Fig](#pone.0219886.s001){ref-type="supplementary-material"}. Once the contributing weight of donor and acceptor was determined, FRET efficiency was estimated using the following equation\[[@pone.0219886.ref027]\]: $$E = \frac{W_{A}}{\left( \frac{{QY}_{A}}{{QY}_{D}} \right)W_{D} + W_{A}}\ x\ 100\%$$ where E is the FRET efficiency, W~A~ and W~D~ are the component weights of the donor only and acceptor only emissions calculated through linear unmixing, and QY~A~ and QY~D~ is the quantum yield of the acceptor and donor respectively.

Fluorescent lifetime imaging microscopy (FLIM) {#sec006}
----------------------------------------------

For FLIM experiments, cells were used 1-day post transfection unless otherwise noted. 30 minutes before experiments begin, media was exchanged for imaging buffer and allowed to come to room temperature. Coverslips were transferred to a custom-built chamber and mounted onto the stage of an Olympus FluoView 1000-MP Multiphoton and Scanning Confocal Microscope (Olympus; Tokyo, Japan). Excitation of samples was achieved using a Mai Tai Ti:Sapphire Femtosecond Pulse Laser (Spectra-Physics; Santa Clara, CA) tuned to 950 nm. Fluorescent decays were collected using a XLPlan N 25x (NA 1.05) water immersion objective (Olympus) at 256x256 resolution and a pixel dwell time of 20 μsec. The data was passed by the microscope to the FLIM set up, consisting of two H7422P Hamamatsu detectors (Hamamatsu; Hamamatsu City, Japan) and a time-correlated single photon counting card (Becker and Hickl; Berlin, Germany). To separate donor and acceptor emission, a BrightLine FF552-Bi02-25x36 dichroic (Semrock; Rochester, NY) was used. Emission light to the donor detector was further filtered with a BrightLine FF01-510/42-25 filter and emission to the acceptor detector was filtered with a BrightLine FF01-609/54-25 filter (Semrock). The microscope was controlled with the FV10-ASW software package (Olympus) and the FLIM system was controlled via the VistaVision by ISS software package (ISS Inc; Champaign, IL). Analysis of single cell lifetime decays was performed with VistaVision by ISS and subsequent lifetimes were analyzed in Microsoft Excel (Microsoft Corporation; Redmond, WA). Briefly, cells were isolated into individual regions of interest (ROIs), and the decay data for each pixel in the region above threshold were summed to create a cell fluorescence decay curve. These decay curves were then fit and lifetimes were extracted using non-linear regression in tail-fitting mode. Almost all decay curves were well described by a single exponential fit (as determined by Chi-squared analysis as well as by eye). Lifetimes were extracted from these fits and used to calculate FRET efficiency using the following equation\[[@pone.0219886.ref028]\]: $$E = 1 - \left( \frac{\tau_{DA}}{\tau_{D}} \right)$$

Where E is the FRET efficiency, 𝜏~DA~ is the lifetime of the donor in the presence of acceptor, and 𝜏~D~ is the lifetime of the donor only species (in this case, the average lifetime of NG-Stop). For experiments where acceptor photobleaching was preformed, cells were bleached by scanning with a 559 nm laser at 100% power for 15 minutes under the same parameters that the lifetime data was collected.

Confocal microscopy {#sec007}
-------------------

For confocal microscopy experiments, cells were used 1-day post transfection. 30 minutes before experiments began, media was exchanged for imaging buffer and allowed to come to room temperature. Images were then collected on the same microscope as the FLIM data utilizing a SIM scanner and 488 nm and 559 nm conventional laser lines. Widefield confocal images were collected through a XLUMPlanFl 20X (NA 0.95) water immersion objective (Olympus) at a resolution of 2048x2048. The sample was excited, and emission collected in each channel individually to prevent blead through. Green emission was collected through a 505--540 nm filter and red emission was collected through a 575--675 nm filter. All imaging parameters were kept consistent across experiments to facilitate comparisons. Data was collected in FV10-ASW software package (Olympus) and exported to the Fiji software package\[[@pone.0219886.ref029]\] for analysis as described in the main text and [S3 Fig](#pone.0219886.s003){ref-type="supplementary-material"} using the Coloc2 plugin.

Immunoblotting {#sec008}
--------------

Samples for immunoblotting were harvested 24 hours after transfection. Cells were removed from their culture dish and washed twice with calcium and magnesium free DPBS (Corning). Following cell lyses in the presence of protease inhbitors, protein concentrations were evaluated using a Pierce^TM^ BCA Protein Assay Kit (ThermoFisher Scientific) and 10 μg of total protein was loaded into a 16% SDS-PAGE gel. After electrophoresis, proteins were transferred to a 0.2 μm nitrocellulose membrane (BioRad; Hercules, CA). Presence of the mNeonGreen protein was probed using a monoclonal mouse anti-mNeonGreen antibody \[32F6\] (Chromotek; Planegg-Martinsried, Germany) at a 1:1000 dilution and visualized using a donkey anti-mouse IgG DyLight 680 secondary antibody (ThermoFisher Scientific) at a 1:5000 dilution. The same membrane was additionally probed for the presence of mClover3 using a rabbit anti-GFP antibody (ThermoFisher Scientific, A11122) at a 1:1000 dilution and visualized with a goat anti-rabbit IgG DyLight 800 secondary antibody (ThermoFisher Scientific) at a 1:10000 dilution. Detection was completed using an Odyssey 3 Imaging System (Li-cor Biosciences; Lincoln, NE).

Statistics {#sec009}
----------

To avoid assumptions regarding the data distributions, all statistical significance in this manuscript was determined using a permutation test implemented through a custom Python script utilizing the MLxtend library\[[@pone.0219886.ref030]\] using the approximation method with 1,000,000 permutations. For instances where there was less than 10 data points total between the two data sets being compared, an exact method was used.

Results {#sec010}
=======

Physical properties and spectrum of proteins in this study {#sec011}
----------------------------------------------------------

For this study, we utilized the monomeric, yellow-green fluorescent protein mNeonGreen to test the ability of two new red fluorescent proteins, mRuby3 and mScarlet-I, as well as mCherry to act as FRET acceptors. The fluorescent and physical properties of these proteins are listed in [Table 1](#pone.0219886.t001){ref-type="table"}. mNeonGreen is one of the brightest fluorescent proteins to date with a high quantum yield and extinction coefficient making its signals easy to observe. In addition, mNeonGreen is also highly photostable\[[@pone.0219886.ref004]\], and matures quickly, making it an ideal FRET donor. Both mRuby3 and mScarlet-I have high extinction coefficients, poising them to be excellent FRET acceptors. In comparison to mCherry, these proteins also offer substantially higher quantum yield, indicating that it will be easier to detect energy transfer events using the emission of one of these two proteins. The absorbance and emission spectrum of mNeonGreen is overlaid with the spectrum of mRuby3, mScarlet-I and mCherry in [Fig 1A--1C](#pone.0219886.g001){ref-type="fig"}. For each red fluorescent protein, the overlap integral (J(λ)) and Förster radius (R~0~) values with mNeonGreen are listed in [Table 1](#pone.0219886.t001){ref-type="table"}. Based on these photophysical properties, all three red FPs are expected to FRET with mNeonGreen. Assuming identical positioning between donor and acceptor, mRuby3 is expected to produce the highest FRET efficiency and mCherry the lowest FRET efficiency with mNeonGreen.

![Spectrum of mNeonGreen, mRuby3, mScarlet-I and mCherry.\
Absorbance (dashed lines) and emission spectrum (solid lines) of purified mNeonGreen (green lines) overlaid with the spectrum of purified mRuby3 **(A)**, mScarlet-I **(B)**, and mCherry **(C)**. Spectrum were obtained from the reference indicated in [Table 1](#pone.0219886.t001){ref-type="table"}.](pone.0219886.g001){#pone.0219886.g001}
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###### Properties of the fluorescent proteins used in this study.

![](pone.0219886.t001){#pone.0219886.t001g}

  -------------------------------------------------------------------------------------------------------------------------------
  Protein         Ref   𝜆~ex~ max\   𝜆~em~ max\   EC\             QY     pKa   Maturation\   J(λ)\                        R~0~\
                        (nm)         (nm)         (M^-1^cm^-1^)                (min)         (x10^15^ M^-1^cm^-1^nm^4^)   (Å)
  --------------- ----- ------------ ------------ --------------- ------ ----- ------------- ---------------------------- -------
  **Donors**                                                                                                              

  mNeonGreen      4     506          517          116,000         0.8    5.7   10            \-                           \-

  mClover3        10    506          518          109,000         0.78   6.5   43.5          \-                           \-

  **Acceptors**                                                                                                           

  mRuby3          10    558          592          128,000         0.45   4.8   136.5         4.65                         64

  mScarlet-I      11    569          593          104,000         0.54   5.4   36            3.60                         61

  mCherry         6     587          610          72,000          0.22   4.5   15            2.28                         57

  mScarlet        11    569          594          100,000         0.7    5.3   174           3.51                         61
  -------------------------------------------------------------------------------------------------------------------------------

𝜆~ex~ max = emission maximum, 𝜆~em~ = emission maximum, EC = extinction coefficient, QY = quantum yield, J(𝜆) = overlap integral, R~0~ = Förster Radius. J(𝜆) and R~0~ are calculated with mNeonGreen as the donor, an orientation factor of 0.6667, and a refractive index of 1.33. Values were obtained from the references listed under the Ref column.

mNeonGreen-RFP tandem constructs reveal poor performance of mRuby3 {#sec012}
------------------------------------------------------------------

To test the ability of the red FPs to act as FRET acceptors, we constructed tandem FP constructs consisting of the full coding sequence of mNeonGreen (NG) followed by a short amino acid linker (SGLSKGEE) and then the full coding sequence of the red FP ([Fig 2A](#pone.0219886.g002){ref-type="fig"} with the amino acid sequences available in [S1 Table](#pone.0219886.s008){ref-type="supplementary-material"} in the Supplemental Information). Although an 8 amino acid linker is relatively short, inclusion of the full mNeonGreen c-terminus (which appears unstructured or absent in the mNeonGreen structure\[[@pone.0219886.ref031]\]) creates an effective linker of 17 amino acids. A mNeonGreen-Stop construct was also created, which contains the full coding sequence of mNeonGreen, the 8 amino acid linker, and then a stop codon to act as a donor only control construct. To determine if mNeonGreen will FRET with the red FPs in these constructs, we transiently transfected each construct into HEK293 cells and measured the acceptor FP emission upon excitation with a wavelength that will only excite the donor. When cells expressing the NG-Stop constructs are excited with 470 nm light, a spectrum comparable to what has been reported for purified mNeonGreen was obtained ([Fig 2B](#pone.0219886.g002){ref-type="fig"}, [S1 Fig](#pone.0219886.s001){ref-type="supplementary-material"} in the Supplemental Information). When the NG-red FP tandem constructs are assayed, a second peak emerges corresponding to the red FP. Example spectrum for the NG-mRuby3, NG-mScarlet-I, and NG-mCherry constructs are shown in [Fig 2C, 2D and 2E](#pone.0219886.g002){ref-type="fig"} respectively in pink, along with calculated donor (green) and acceptor components (red) determined through linear unmixing, as well as the fit (black dashed line) resulting from the addition calculated donor and acceptor components. Note that in all cases, the unmixing fit faithfully reproduced the raw data traces. Using the donor and acceptor components, the FRET efficiency of each construct can be estimated using Eq. 1 ([Fig 2F](#pone.0219886.g002){ref-type="fig"}, with the raw traces available in [S1 Fig](#pone.0219886.s001){ref-type="supplementary-material"}). Over three independent transfections for each construct, the NG-mScarlet-I and NG-mCherry construct presented a FRET efficiency of 29 ± 0.5% and 22 ± 0.8% respectively. Surprisingly, the NG-mRuby3 construct presented an estimated FRET efficiency of 16 ± 0.1%. This poor performance in comparison to NG-mScarlet-I or NG-mCherry was highly unexpected considering the physical and spectral properties reported for mRuby3\[[@pone.0219886.ref010]\], which predicted it would be the best FRET acceptor of the three red FPs for mNeonGreen.

![Spectral FRET of each mNeonGreen-Red FP tandem constructs.\
**(A)** Cartoon schematic of the mNeonGreen-Red FP tandem constructs used for FRET experiments. **(B)** Average emission scan of cells expressing NG-Stop (black) when excited at 470 nm overlaid with the reported spectrum for purified mNeonGreen in green (n = 3 independent transfections). Example raw emission spectrum (pink) of tandem **(C)** NG-mRuby3, **(D)** NG-mScarlet-I, and **(E)** NG-mCherry when excited at 470 nm. The dashed black line shows the sum of donor (green) and acceptor (red) components calculated by linear unmixing. **(F)** FRET efficiencies calculated from the spectrum for each construct (n = 3). \*\*\* = P \< 0.0005 between the indicated conditions.](pone.0219886.g002){#pone.0219886.g002}

mNeonGreen is a suitable donor for two-photon FLIM {#sec013}
--------------------------------------------------

To confirm our spectral FRET findings, we turned to the more precise method of 2-Photon Fluorescent Lifetime Imaging (FLIM). We first sought to determine if mNeonGreen was a suitable donor for 2-Photon FLIM experiments. A well-behaved FRET donor would be easily excited by the 2-photon laser, be stable under a variety of 2-photon laser powers, and display a stable, mono-exponential lifetime\[[@pone.0219886.ref032]\]. To our knowledge, there is only one report of mNeonGreen's performance using two-photon illumination\[[@pone.0219886.ref033]\]. This study demonstrated that blue shifted fluorescent proteins tend to perform better under 2-photon excitation than more yellow shifted fluorescent proteins but did not preclude mNeonGreen's use from two-photon based studies. Using 950 nm light and the NG-Stop construct, we assayed mNeonGreen's performance in 2-photon FLIM over various conditions using Time Correlated Single Photon Counting. Over a variety of laser powers, mNeonGreen produced a stable lifetime of 3.05 ± 0.01 ns over 50 frames of acquisition ([Fig 3A](#pone.0219886.g003){ref-type="fig"}). This lifetime was stable for up to 300 frames of acquisition for all but the highest laser power tested, 25 W/cm^2^ in which the lifetime linearly decayed to 87 ± 4.5% of its initial value after 300 frames ([Fig 3B](#pone.0219886.g003){ref-type="fig"}). In contrast, significant photobleaching was observed for laser powers above 15 W/cm^2^ ([Fig 3C](#pone.0219886.g003){ref-type="fig"}) with 20 W/cm^2^ and 25 W/cm^2^ bleaching approximately 48 ± 14% and 94 ± 3% of the sample intensity respectively after 300 frames. Example decay traces of a single cell collected in consecutive 50 frame intervals are shown at 15 W/cm^2^ ([Fig 3D](#pone.0219886.g003){ref-type="fig"}) and 25 W/cm^2^ ([Fig 3E](#pone.0219886.g003){ref-type="fig"}). Normalizing the decay traces to the peak intensity for the 25 W/cm^2^ example demonstrates the reduction in lifetime and the decay in data quality over the course of acquisition at this power ([Fig 2F](#pone.0219886.g002){ref-type="fig"}). To serve as a comparison, we repeated these experiments using EGFP ([S2 Fig](#pone.0219886.s002){ref-type="supplementary-material"}). EGFP produced a stable lifetime of 2.63 ± 0.01 ns over various laser powers. Similar to mNeonGreen, this lifetime was stable for 300 frames of acquisitions for each laser power other than 25 W/cm^2^. Additionally, power levels above 15 W/cm^2^ also induced significant photobleaching over 300 frames, although to a lesser degree than what was observed with mNeonGreen ([S2 Fig](#pone.0219886.s002){ref-type="supplementary-material"}). Given these data, we concluded that mNeonGreen is a suitable donor for two-photon FLIM experiments when the lifetime is acquired at a laser power of 15 W/cm^2^ or less. For all further FLIM experiments, data was collected at laser powers between 5--10 W/cm^2^ for 100--150 frames depending on the brightness of the cell.

![mNeonGreen performs well under various laser powers for two-photon time domain FLIM acquisitions.\
**(A)** Lifetime data collected from individual HEK293 cells expressing cytosolic mNeonGreen at various laser powers up to 25 W/cm^2^ after 50 frames. Black bars indicate the average ± 95% confidence interval. **(B)** Lifetime and **(C)** intensity of samples taken over 300 frames at various laser powers. \* = P \< 0.05, \*\* = P\< 0.005, and \*\*\* = P \< 0.0005 compared to the frame matched 5W/cm^2^ dataset. N for each sample is as follows 5W/cm^2^: 11 cells, 10W/cm^2^: 10 cells, 15W/cm^2^: 14 cells, 20W/cm^2^: 9 cells, 25W/cm^2^: 11 cells. **(D)** Example lifetime decay curves obtained at 15 W/cm^2^ over 300 frames. **(E)** Example lifetime decay and normalized decays **(F)** obtained at 25 W/cm^2^ over 300 frames.](pone.0219886.g003){#pone.0219886.g003}

FLIM-FRET measurements confirm poor performance of mRuby3 {#sec014}
---------------------------------------------------------

With FLIM, FRET is detected as a reduction of the donor's lifetime when in the presence of the acceptor\[[@pone.0219886.ref028]\]. This technique has the advantage of determining the FRET state between mNeonGreen and the red FP independent of the red FPs emission, allowing us to determine the FRET efficiency for each construct without having to account for the differences between each red FPs. Over the course of several independent transfections, the mNG-Stop construct produced a donor only lifetime of 3.05 ± 0.02 ns ([Fig 4A](#pone.0219886.g004){ref-type="fig"}). When mScarlet-I or mCherry are present in the tandems, mNeonGreen's lifetime is reduced to 2.22 ± 0.06 ns and 2.23 ± 0.03 ns respectively ([Fig 4A](#pone.0219886.g004){ref-type="fig"}). This results in a FRET efficiency of the NG-mScarlet-I construct of 27 ± 2% and an efficiency of 27 ± 1% for the NG-mCherry construct ([Fig 4B](#pone.0219886.g004){ref-type="fig"}). Assay of the NG-mRuby3 construct shows even worse performance of mRuby3 than what was estimated with spectral FRET ([Fig 2F](#pone.0219886.g002){ref-type="fig"}). The average lifetime of the NG-mRuby3 construct was 2.92 ± 0.03 ns ([Fig 4A](#pone.0219886.g004){ref-type="fig"}) resulting in a FRET efficiency of only 4 ± 0.9% ([Fig 4B](#pone.0219886.g004){ref-type="fig"}). Indeed, 35 cells across 3 independent transfections (over half of all cells sampled) exhibited lifetimes within the range of what was collected for the NG-Stop construct, whereas no cells expressing NG-mScarlet-I or NG-mCherry had lifetimes within that range ([Fig 4A](#pone.0219886.g004){ref-type="fig"}). Example decay traces representative of the average for each construct are shown in [Fig 4C](#pone.0219886.g004){ref-type="fig"} and example lifetime maps of HEK293 cells expressing each construct are shown in [Fig 4D](#pone.0219886.g004){ref-type="fig"}.

![Lifetime of mNeonGreen-Red FP tandem constructs.\
**(A)** The lifetime of mNeonGreen in individual cells expressing a mNeonGreen-Red Protein tandem fusion construct. Black bars indicate the average ± 95% confidence interval. **(B)** FRET efficiency calculations for each tandem construct. \*\*\* = P \< 0.0005 compared to NG-Stop and \# indicates P \< 0.0005 compared to NG-Stop and P \< 0.0005 compared to NG-mRuby3. NG-mScarlet-I and NG-mCherry are not statistically different (P = 0.75) **(C)** Example decay curves for each tandem representative of the average lifetime of all cells for each construct. **(D)** Example lifetime heat maps for a single frame for each construct. N for each construct is as follows NG-Stop: 68 cells, NG-mRuby3: 63 cells, NG-mScarlet-I: 64 cells, and NG-mCherry: 64 cells.](pone.0219886.g004){#pone.0219886.g004}

Confocal imaging demonstrates lower than expected red fluorescence for mNeonGreen-mRuby3 construct {#sec015}
--------------------------------------------------------------------------------------------------

To further investigate the poor performance of mRuby3 as a FRET acceptor, we turned to confocal microscopy to analyze the behavior each tandem construct. The presence of mNeonGreen and the red FPs were independently surveyed via sequential excitation with a 488 nm and 559 nm lasers, with the emissions of each channel being collected separately to prevent bleed through. Example wide field images of cells expressing each construct are shown in [Fig 5A](#pone.0219886.g005){ref-type="fig"}. Qualitatively, it can be seen in the merged image of the green and red channels that the cells expressing the NG-mRuby3 construct had widely varying intensities of green and red fluorescence. Interestingly, cells were regularly observed that seem to contain high levels of mNeonGreen and low levels of mRuby3 or vice versa, alongside cells that appeared to contain both proteins. This heterogeneity was also noted in with the NG-mScarlet-I and NG-mCherry constructs, but with much less frequency ([Fig 5A](#pone.0219886.g005){ref-type="fig"}). This result was quite surprising given the constructs were designed to express mNeonGreen and the red FP stoichiometrically and in tandem. Theoretically, we would expect expression of such tandem constructs to result in a fixed ratio of green to red intensity where the red intensity varies depending on the brightness of the red FP and the green intensity varying due to changes in the extent of FRET. To test this prediction and quantify the heterogeneity for each construct we examined regions of interest (ROI) containing a single cell, extracted the green and red intensities for that cell following background subtraction, and plotted the resulting intensities at the pixel level. The resulting green-red intensity plots for each cell were then fit with a linear regression. An example of this workflow is diagramed in [S3 Fig](#pone.0219886.s003){ref-type="supplementary-material"}. While the absolute value of this slope will be different for each fluorophore pair and for different imaging conditions, the changes in this slope from cell to cell under the same imaging conditions will report the heterogeneity of each construct. As expected of a tandem construct and based on qualitative assessments of images ([Fig 5A](#pone.0219886.g005){ref-type="fig"}), histograms of the slopes for individual cell expressing the NG-mCherry and NG-mScarlet-I constructs revealed a reasonable distribution and narrow spread of slopes ([Fig 5C and 5D](#pone.0219886.g005){ref-type="fig"}). This indicates the majority of cells expressing these constructs contain a fixed ratio of mNeonGreen to red FP. In contrast, the histogram of slopes from cells expressing NG-mRuby3 were not as evenly distributed ([Fig 5B](#pone.0219886.g005){ref-type="fig"}). Indeed, the majority of cells expressing this construct have a slope close to 0, suggesting that these cells contain measurable mNeonGreen levels but low levels of fluorescent mRuby3. Interestingly, this lack of abundant red fluorescence does not stem from a lack of mRuby3 protein as western blotting of cells transfected with NG-mRuby3 produce a similar banding pattern as those transfected with NG-mScarlet-I and NG-mCherry ([S4 Fig](#pone.0219886.s004){ref-type="supplementary-material"}). Importantly, in NG-mRuby3 transfected cells there is no smaller monomer sized band, indicating our tandem constructs are generally intact and ruling out the possibility of mNeonGreen being produced without mRuby3. Taken together, these data provide a mechanistic explanation for our FLIM data in which all cells expressing the NG-mScarlet-I and NG-mCherry constructs exhibited robust FRET, whereas a large majority of NG-mRuby3 constructs did not. Further, they suggest that the poor performance of NG-mRuby3 may be due to poor maturation of the acceptor compared to NG-mScarlet-I and even NG-mCherry.

![Confocal microscopy of the tandem constructs.\
**(A)** Example images of NG-Red FP constructs when directly excited by 499 nm or 559 nm lasers. Histograms of the slopes of the red/green intensity correlations for individual cells expressing **(B)** NG-mRuby3 (n = 1077 cells), **(C)** NG-mScarlet-I (n = 1745 cells), and **(D)** NG-mCherry (n = 1557 cells).](pone.0219886.g005){#pone.0219886.g005}

mRuby3 exhibits similar behavior in several configurations and similar behavior to the slow maturing mScarlet variant {#sec016}
---------------------------------------------------------------------------------------------------------------------

To better determine if mRuby3's behavior was specific to our system, or intrinsic to mRuby3 itself, we developed several additional tandem constructs. First, we swapped the orientation of the tandem to see if mRuby3 was more tolerant of c-terminal fusions and changed the linker to a slightly smaller glycine-serine linker (GGSGG). This mRuby3-GGSGG-NG construct preformed similarly the original NG-mRuby3 construct, producing an average lifetime of 2.96 *±* 0.02 ns ([Fig 6A](#pone.0219886.g006){ref-type="fig"}) corresponding to a FRET efficiency of 4 *±* 1% ([Fig 6B](#pone.0219886.g006){ref-type="fig"}). Confocal analysis of this construct ([Fig 6C and 6D](#pone.0219886.g006){ref-type="fig"}) also reveals a similar phenotype to NG-mRuby3, where the majority of cells have slopes close to 0, indicating most cells have detectable mNeonGreen fluorescence, but lack mRuby3 fluorescence. Next, we inserted an optimized self-splicing peptide sequence (P2A peptide)\[[@pone.0219886.ref034]\] between NG and mRuby3 in the NG-Ruby3 construct. This sequence causes a ribosomal skipping event during translation that will result in the release of the NG polypeptide from the ribosome during translation, before re-initiating translating the mRuby3 portion of the construct, resulting in two separate proteins being translated from the same transcript. Notably, we designed the construct so that most of the extra P2A peptide sequence will be appended to NG, with the only addition to mRuby3 being an N-terminal proline upon successful cleavage. Cells expressing NG-P2A-mRuby3 exhibited an average lifetime of 3.09 *±* 0.01 ns ([Fig 6A](#pone.0219886.g006){ref-type="fig"}) and displayed lifetimes that were statistically indistinguishable from the lifetimes of cells expressing NG-Stop, collected on the same day. This result was expected as the NG and mRuby3 in these cells should no longer be linked together, and indeed, western blot analysis of this construct confirms the P2A peptide is cleaving with high efficiency ([S4 Fig](#pone.0219886.s004){ref-type="supplementary-material"}). Unfortunately, though this construct shows only a minor improvements in the behavior of mRuby3 as determined by confocal analysis ([Fig 6C and 6E](#pone.0219886.g006){ref-type="fig"}), which still showed a high portion of cells with near zero slopes, but did also exhibit a secondary, non-zero peak.

![Behavior of distinct mRuby3 and mScarlet containing tandem constructs.\
**(A)** The lifetimes of a distinct set of NG-Stop express cells with the lifetimes of 2 new mRuby3 containing tandem constructs and an mScarlet containing construct. Black bars indicate the average ± 95% confidence interval. \*\*\* = P \< 0.0005 compared to NG-Stop. NG-Stop and NG-P2A-mRuby3 are not statistically different (P = 0.65). N for the lifetime measurements of each construct is as follows NG-Stop: 64 cells, mRuby3-GGSGG-NG: 66 cells, NG-P2A-mRuby3: 69 cells, and NG-mScarlet: 77 cells. **(B)** Average FRET efficiency for each of the new tandem constructs. **(C)** Example merge confocal images of HEK293 cells expressing each of the new tandem constructs. Pooled histograms of the slopes of cells expressing **(D)** mRuby3-GGSGG-NG, **(E)** NG-P2A-mRuby3, and **(F)** NG-mScarlet. N for the confocal measurements of each construct is as follows mRuby3-GGSGG-NG: 2302 cells, NG-P2A-mRuby3: 1548 cells, and NG-mScarlet: 1150 cells.](pone.0219886.g006){#pone.0219886.g006}

While mScarlet-I and mCherry mature with a half-time of 36 and 15 minutes respectively, mRuby3 is reported as having a maturation half-time of 136.5 minutes. To test if the large difference in maturation times could result in the phenotype we see for mRuby3, we mutated the mScarlet-I in the NG-Scarlet-I tandem to the bright but slow maturing Scarlet variant, mScarlet, by introducing a I74T mutation. This slow maturing variant is reported as having a maturation half-time of 132.4 minutes under the same conditions as the mRuby3 maturation measurements were made. Cells expressing NG-mScarlet presented highly variable lifetimes averaging to 2.67 *±* 0.05 ns resulting in an average FRET efficiency of 13 *±* 2% ([Fig 6A and 6B](#pone.0219886.g006){ref-type="fig"}). Under confocal, cells expressing this NG-Scarlet also display a heterogeneous phenotype ([Fig 6C](#pone.0219886.g006){ref-type="fig"}) but, a majority of cells exhibit a non-zero slope indicating that most cells exhibit both green and red fluorescence ([Fig 6F](#pone.0219886.g006){ref-type="fig"}).

Lastly, we turned to analyzing mRuby3's behavior with an evolutionarily distinct green FP, mClover3. Using a mClover3-mRuby3 tandem construct available from Addgene, we created a mClover3-Stop construct to serve as a donor only control and analyzed the ability of mRuby3 to act as an acceptor for mClover3 using FLIM. In addition to using a different green FP, this construct also uses a 12 amino acid linker rather than the effective 17 or 15 amino acid linkers we have used thus far ([S1 Table](#pone.0219886.s008){ref-type="supplementary-material"}). Cells expressing mClover3-Stop exhibit a stable monoexponential lifetime of 3.11 *±* 0.01 ns ([S5 Fig](#pone.0219886.s005){ref-type="supplementary-material"}). When mRuby3 is present in the construct to act as an acceptor, this lifetime is reduced to 2.81 *±* 0.05 ns on average ([S5 Fig](#pone.0219886.s005){ref-type="supplementary-material"}). This results in an average FRET efficiency of 10 *±* 2%. It is also worth noting that similar to NG-mScarlet, mClover3-mRuby3 exhibited a large range of lifetimes. Given that mClover3's spectral and physical properties are very similar to mNeonGreen's, this seems to indicate a slight improvement in performance on mRuby3's behalf, either due to the sorter linker, or the inclusion of mClover3 over mNeonGreen. Regardless though, a high heterogeneity is still seen with the expression of this tandem ([S5 Fig](#pone.0219886.s005){ref-type="supplementary-material"}) indicating the underlying problems with mRuby3 are still present.

Expressing mNeonGreen-mRuby3 for longer periods of time improves its performance {#sec017}
--------------------------------------------------------------------------------

Our previous data has suggested that mRuby3's poor acceptor properties may in part be due to inefficient maturation. To test this further, we performed FLIM experiments for up to five days following transient transfection with the NG-mRuby3 construct. As seen in [Fig 7A](#pone.0219886.g007){ref-type="fig"}, the average lifetime of mNeonGreen in the NG-mRuby3 construct decreases from 2.92 ± 0.03 ns 1-day post transfection (DPT) to 2.41 ± 0.09 ns 5 DPT. This results in a change in average FRET efficiency of 4 ± 0.9% 1 DPT to an efficiency of 21 ± 3% efficiency 5 DPT transfection ([Fig 7B](#pone.0219886.g007){ref-type="fig"}). Example lifetime maps of individual cells expressing NG-mRuby3 2--5 DPT are shown in [Fig 7C](#pone.0219886.g007){ref-type="fig"}, with the example lifetime map for 1 DPT shown in [Fig 4D](#pone.0219886.g004){ref-type="fig"}. Example fluorescent decay traces for each DPT are available in [S6 Fig](#pone.0219886.s006){ref-type="supplementary-material"}. As time progressed, the number of cells exhibiting lifetimes within the range of the NG-Stop also decreased. However, even 5 DPT cells could still be observed that exhibited donor only like lifetimes. This indicates that although inefficient maturation in mammalian cells may be part of the reason mRuby3 performs poorly in previous experiments, it is likely not the only contributing factor. To ensure that the changes observed over time for the NG-mRuby3 construct were due to changes occurring to the mRuby3 protein, and not mNeonGreen, mNeonGreen lifetimes of the NG-mRuby3 constructs were determined before and after acceptor photobleaching on 5 DPT ([Fig 7D](#pone.0219886.g007){ref-type="fig"}). Regardless of the lifetime each cell exhibited before acceptor photobleaching, all cells exhibited lifetimes similar to that of the NG-Stop construct after acceptor photobleaching. [Fig 7F](#pone.0219886.g007){ref-type="fig"} shows example lifetime maps of two cells expressing NG-mRuby3 5 days post transfection before and after acceptor photobleaching and example fluorescent decay traces can be found in [S6 Fig](#pone.0219886.s006){ref-type="supplementary-material"}. These findings demonstrate that the mNeonGreen lifetime remained stable over the course of 5 days, indicating that the changes the NG-mRuby3 construct underwent was due to changes occurring to the mRuby3 protein.

![FRET of NG-mRuby3 1--5 days post transfection.\
**(A)** Lifetimes of cells expressing NG-mRuby3 construct 1--5 days post transfection (DPT) with 1 DPT is replicated from [Fig 3A](#pone.0219886.g003){ref-type="fig"} for reference. Black bars indicated the average lifetime ± 95% confidence interval. The green shading indicates the range of lifetimes observed from the NG-Stop construct. \*\*\* = P \< 0.0005 compared to 1 DPT, and \# = P \< 0.0005 compared to 1 DPT and P \< 0.0005 compared to the day before. N for each condition is as follows, 2 DPT: 30 cells, 3 DPT: 34 cells, 4 DPT: 35 cells, and 5 DPT: 31 cells. **(B)** Average FRET efficiency of NG-mRuby3 1--5 DPT. **(C)** Example lifetime maps collected each day tested. **(D)** Lifetime data from NG-mRuby3 expressing cells 5 days post transfection before and after acceptor photobleaching (n = 15). \*\*\* = P \< 0.0005 after photobleaching compared to before photobleaching. **(E)** Example lifetime maps of the same cells before and after acceptor photobleaching.](pone.0219886.g007){#pone.0219886.g007}

Discussion {#sec018}
==========

Development and verification of bright monomeric Green/Red FP pairs will greatly increase the general adoption of Green/Red FRET. Bright fluorophores allow for easier detection and greater signal to noise ratio. Using green and red fluorophores specifically has several distinct advantages include reduced toxicity by the excitation source, greater spectral separation, larger Förster radii, and better tissue penetrance of excitation and emission wavelengths. These benefits allow for newer, more accurate and precise studies to be conducted with less confounding factors than what could be done with Cyan/Yellow FRET pairs. mNeonGreen is an ideal donor for Green/Red FRET experiments. Its yellow shifted excitation and emission spectrum allow for a high degree of overlap with red FPs while also being capable of being excited with lower energy blue light than cyan or more blue shifted green FPs. In addition, mNeonGreen is remarkably bright under single-photon illumination, making its signals easy to observe. Both mScarlet-I and mRuby3 are reported as having some of the highest extinction coefficients of any red FPs, as well as also being some of the brightest monomeric red FPs to date. These facts indicate that they should make excellent FRET acceptors, making Green/Red FRET more accessible to researchers. In this study, we aimed to test this prediction using a variety of optical techniques.

We tested the ability of these two new red FPs--mRuby3 and mScarlet-I--along with mCherry to act as FRET acceptors for mNeonGreen using a tandem protein approach. Initially we used intensiometric spectral FRET to estimate the FRET efficiency between mNeonGreen and the red FPs ([Fig 2](#pone.0219886.g002){ref-type="fig"}). In this assay NG-mScarlet-I demonstrated the highest FRET efficiency, followed by NG-mCherry, and then NG-mRuby3 ([Fig 2F](#pone.0219886.g002){ref-type="fig"}). This was surprising given the reported properties of mRuby3 predicted that it would be the best acceptor for mNeonGreen. Specifically, mRuby3 had the highest degree of overlap between its excitation spectrum and mNeonGreen's emission spectrum and it has the highest extinction coefficient of the three red FPs in this study ([Table 1](#pone.0219886.t001){ref-type="table"}). These experiments also demonstrated the advantages of these newer proteins over mCherry, as mScarlet-I produced almost 3 times the intensity of mCherry, despite only a 7% difference in estimated efficiency, and mRuby3 produced almost 1.5 times the intensity of mCherry, despite NG-mRuby3 exhibiting a lower FRET efficiency than NG-mCherry. This reflects the difference in extinction coefficient and quantum yield between these two proteins and mCherry and demonstrates how mScarlet-I is a better overall acceptor that will provide more signal and greater dynamic range for intensiometric green-red based FRET experiments.

To confirm these results, we turned to a more precise technique, FLIM. FLIM has the advantages of only needing to observe only the donor, there for eliminating the need to correct our data for differences in the acceptors physical properties as reported by others. In addition, our FLIM set up allows for assaying single cells to allow for a more detailed profile of the tandem construct's behavior. After establishing mNeonGreen as a suitable donor for 2-Photon FLIM experiments ([Fig 3](#pone.0219886.g003){ref-type="fig"}), we used this technique to measure the FRET efficiency of each tandem in the study ([Fig 4](#pone.0219886.g004){ref-type="fig"}). We found that both mScarlet-I and mCherry were able to efficiently FRET with mNeonGreen as almost to the same degree, but that mRuby3 was unable to induce substantial FRET ([Fig 4A and 4B](#pone.0219886.g004){ref-type="fig"}). It was somewhat surprising to see mCherry preformed just as well as mScarlet-I as a FRET acceptor in our FLIM experiments, despite having a significantly lower extinction coefficient. This may be a demonstration of mCherry's fast maturation, which may allow for the highest possible amount of fully developed tandems. To further investigate mRuby3s poor performance, we employed confocal microscopy to reveal great heterogeneity in the way the NG-mRuby3 tandem expresses ([Fig 5A and 5B](#pone.0219886.g005){ref-type="fig"}), with many cells exhibiting either red or green fluorescence, without the other. This was in spite of western blotting analysis suggesting that most cells should be expressing the full-length tandem protein ([S4 Fig](#pone.0219886.s004){ref-type="supplementary-material"}). This behavior was consistent across three additional mRuby3 constructs ([Fig 6](#pone.0219886.g006){ref-type="fig"}). Changing the orientation of the constructs and shortening the linker between them (Ruby3-GGSGG-NG) seemed to have virtually no effect on mRuby3's performance as an acceptor, or the observed heterogeneity under confocal ([Fig 6](#pone.0219886.g006){ref-type="fig"}). Only minor improvements were observed under confocal with the NG-P2A-mRuby3 construct which would allow mRuby3 to mature without being covalently linked to NG (a conformation which prevented FRET but allowed us to assess mRuby3's behavior as an independent protein). Notably, this behavior was similar to what was observed with the slow maturing Scarlet variant, mScarlet ([Fig 6](#pone.0219886.g006){ref-type="fig"}), suggesting mRuby3's poor performance may be due to its longer maturation time. Given these findings, were conducted experiments on the NG-mRuby3 construct several days following transfection and indeed found that allowing the NG-mRuby3 construct more time to mature improved its performance as a FRET acceptor ([Fig 7](#pone.0219886.g007){ref-type="fig"}).

In theory, the higher extinction coefficient and quantum yield of mRuby3 predicts that it should outperform the mCherry and mScarlet-I. Shockingly though, we found the opposite result ([Fig 2](#pone.0219886.g002){ref-type="fig"} and [Fig 4](#pone.0219886.g004){ref-type="fig"}). Even under the most ideal conditions tested (4 or 5 days post transfection), the NG-mRuby3 tandem still did not reach the FRET efficiencies of the NG-mScarlet-I and NG-mCherry tandems ([Fig 7](#pone.0219886.g007){ref-type="fig"}). This is in contrast to a previous report of a similar mNeonGreen-mRuby3 construct preforming very well, achieving nearly 40% efficiency in both HEK293 and Hela cells\[[@pone.0219886.ref010]\]. At this point, the reasons for this discrepancy is unclear, although similarities in linker length and composition, transfection times, and cell types suggest it is not due to a difference between the makeup of the tandem constructs used or differences in the conditions in which the experiments were conducted (for what conditions were reported). This inconsistency also followed through for the mClover3-mRuby3 construct ([S5 Fig](#pone.0219886.s005){ref-type="supplementary-material"}), once again, for reasons unknown. In addition, we found during our experiments that the emission spectrum of mRuby3 in this tandem was slightly left shifted by 6 nm compared to what is reported purified mRuby3\[[@pone.0219886.ref010]\] ([S1 Fig](#pone.0219886.s001){ref-type="supplementary-material"}). This finding was not reported previously and although this shift was slight, it was necessary to correct for it in order to properly fit our data. The cause of this spectral shift remains unclear but may simply be a result of mRuby3 having slightly different behavior in cells verse in a purified system. This may also be due to the photochromic behavior previously reported for mRuby3\[[@pone.0219886.ref011]\]. Whatever the cause, unpredictable changes in spectrum are highly concerning for FRET experiments as they can result in changes in fluorescence intensity that may be misinterpreted as changes in FRET state. It is possible that that this behavior also influenced our spectral FRET experiments ([Fig 2](#pone.0219886.g002){ref-type="fig"}) and could account for the disparity between the calculated FRET efficiencies for the NG-mRuby3 construct in the spectral FRET vs. FLIM assays.

While few studies using mRuby3 have been published to date, studies utilizing its predecessor, mRuby2 report generally positive results\[[@pone.0219886.ref004], [@pone.0219886.ref009]--[@pone.0219886.ref011], [@pone.0219886.ref035], [@pone.0219886.ref036]\]. Although, a similar study to ours using the green FP mClover as a donor reported much lower than expected efficiencies when using mRuby2 as an acceptor\[[@pone.0219886.ref037]\]. A commonality between our study and theirs is the use of mammalian cells lines. This coupled with our data reported here suggest that poor or slow maturation efficiency of the Ruby series is a major contributor to mRuby3's poor performance 1--3 days post transfection. Issues of maturation could also compound with variability in protein turnover rates from cell to cell or protein stability issues, and a combination of these factors likely explains the high degree of heterogeneity we observe under confocal with our mRuby3 constructs as well as with the slow maturing variant of mScarlet ([Fig 5](#pone.0219886.g005){ref-type="fig"} and [Fig 6](#pone.0219886.g006){ref-type="fig"}).

Overall we find that both mCherry and mScarlet-I act as excellent acceptors for mNeonGreen within our model system, with each protein offering distinct advantages depending on the detection systems being utilized. Additionally, we demonstrated how factors beyond classically considered FRET parameters (donor quantum yield, spectral overlap, and acceptor extinction coefficient) can affect FRET systems in unpredictable ways. It was one of these "non-classic" factors, maturation time, that causes us to conclude that use of mRuby3 (and possibly the slow maturing mScarlet) should only be done with extreme caution where the drawbacks we experienced (heterogenous expression and poor performance shortly after expression begins) will be mitigated or outweighed by potential advantages of mRuby3. It is also important to consider that each of these proteins may behave differently in different systems. This remains a possible explanation for the differences between our data and that reported by others, and our conflicting data underscores the importance of well thought out testing and controls particularly when developing more complex FRET system.

Conclusion {#sec019}
==========

In this study, we test the viability of mNeonGreen as a FRET donor, and mRuby3, mScarlet-I, and mCherry as FRET acceptors with a tandem FP model system. We find that mNeonGreen performs well as a FRET donor in both intensiometric and 2-photon FLIM experiments. When testing the red FPs as acceptors for mNeonGreen, we found that both mScarlet-I and mCherry were readily able to FRET with mNeonGreen. These proteins preformed equally well in FLIM experiments, but mScarlet-I outperformed mCherry in the intensiometric study due to its higher quantum yield. However, when FRET detection is measured independent of acceptor emission intensity, such as in our FLIM system, mCherry demonstrates equal FRET efficiency but more consistent expression, making it a superior choice over mScarlet-I in this scenario. In contrast, we find that mRuby3 performs poorly as a FRET acceptor in our model system, despite it being predicted to be the best FRET acceptor of the three proteins. A major contributor to this poor performance is mRuby3's slow maturation, although protein stability, and cell-to-cell heterogeneity in protein turnover may also contribute or compound this problem.

Overall, we found that mNeonGreen makes an excellent green-yellow donor, and mScarlet-I is one of the best all-around acceptors for green-red FRET experiments utilizing fluorescent proteins.

Supporting information {#sec020}
======================

###### Construct emission scans used for spectral FRET.

**(A)** Emission scans of several independent transfections of NG-Stop when excited at 470 nm overlaid with the reported emission of pure mNeonGreen. The average of these scans is shown in [Fig 2B](#pone.0219886.g002){ref-type="fig"}. Because of the consistency of NG-Stop with the pure mNeonGreen spectrum, the pure mNeonGreen spectrum was used as the donor spectrum for linear unmixing. Acceptor emission scans from several independent transfections of **(B)** NG-mRuby3, **(D)** NG-mScarlet-I, and **(F)** NG-mCherry achieved by exciting the acceptor directly using 530 and 540 nm light, overlaid with the reported pure spectrum for the red FP in each condition. The average of each condition is shown next to the reported pure spectrum for each acceptor is shown in **(C)**, **(E)**, and **(G)** respectively. Scan of both mScarlet-I and mCherry in the NG-mScarlet-I and NG-mCherry constructs faithfully replicated the upstroke and peak of purified mScarlet-I and mCherry, with the major difference between the observed and pure protein spectrum being a faster decay of the tail of the spectrum at high wavelengths. In contrast, the scans of mRuby3 in the NG-mRuby3 construct revealed an emission spectrum that was 6 nm shifted from what was reported for purified mRuby3. Due to the differences seen with each of the red acceptor proteins and varying levels of background, custom acceptor emission spectrums were created to serve as the acceptor emission for linear umixing shown in **(C)**, **(E)**, and **(G)** as the black dashed line. The raw traces used to determine the efficiency of **(H)** NG-mRuby3, **(I)** NG-mScarlet-I, and **(J)** NG-mCherry are shown, corresponding to the efficiency graph in [Fig 2F](#pone.0219886.g002){ref-type="fig"}.

(TIF)

###### 

Click here for additional data file.

###### EGFP performance under 2-Photon FLIM Imaging.

**(A)** Lifetime data collected from individual HEK293 cells expressing cytosolic EGFP at various laser powers up to 25 W/cm^2^ after 50 frames. Black bars indicate the average ± 95% confidence interval. **(B)** Lifetime and **(C)** intensity of samples taken over 300 frames at various laser powers. \* = P \< 0.05, \*\* = P\< 0.005, and \*\*\* = P \< 0.0005 compared to the frame matched 5W/cm^2^ dataset. N for each sample is as follows 5W/cm^2^: 10 cells, 10W/cm^2^: 10 cells, 15W/cm^2^: 10 cells, 20W/cm^2^: 9 cells, 25W/cm^2^: 10 cells.

(TIF)

###### 

Click here for additional data file.

###### Workflow for confocal imaging analysis.

Example workflow demonstrating how confocal images were processed to create intensity slope histograms in [Fig 5](#pone.0219886.g005){ref-type="fig"}.

(TIF)

###### 

Click here for additional data file.

###### Immunoblot of NG-Stop and NG-Red FP tandem constructs.

10 μg of total protein derived from cell transiently transfected with the given construct one day post transfection was loaded into a 16% SDS-PAGE gel and mNeonGreen was visualized using an **(A)** anti-mNeonGreen antibody and **(B)** an anti-GFP (for the detection of mClover3 containg constructs). NG-Stop has presents a band near it's predicted molecular weight of 27kDa. Each of the tandems except NG-P2A-mRuby3, show a bright band at the full predicted weight of the tandem constructs, 54kDA. Importantly, only the NG-Stop and NG-P2A-mRuby3 show bands corresponding to a monomeric mNeonGreen. NG-mCherry, NG-mScarlet-I, NG-mScarlet, and mClover3-mRuby3 show products in between the expected full tandem and the mNeonGreen monomer that are likely due to the hydrolysis of the red FPs backbone during cell lysis and subsequent protein denaturation that has been reported previously with DsRed like red FPs\[[@pone.0219886.ref038]\]. Note that the band that appears between 75 and 100 kDa in **(A)** is present in all lanes indicating that it is a non-specific target of the mNeonGreen antibody.

(TIF)

###### 

Click here for additional data file.

###### mRuby3 performance as a FRET acceptor for the GFP like green-yellow FP mClover3.

**(A)** Confocal merge image of HEK293 cells expressing mClover3-mRuby3 demonstrates that mClover3-mRuby3 also displays high expression heterogeneity, similar to what was seen with other mRuby3 constructs. (B) Lifetimes of HEK293 cells expressing mClover3-Stop (the donor only condition) and mClover3-mRuby3. Each symbol represents a measurement from a single cell. Black bars indicate the average ± 95% confidence interval. N for each sample is as follows, mClover3-Stop: 65 cells and mClover3-mRuby3: 71 cells. \*\*\* = P \< 0.0005 compared to mClover3-Stop. **(C)** The average FRET efficiency of mClover3-mRuby3.

(TIF)

###### 

Click here for additional data file.

###### Example decay curves from the NG-mRuby3 time series.

**(A)** Example fluorescence decay curves of a single cells expressing NG-mRuby3 2--5 days post transfection (DPT) representative of the average for each condition. The NG-Stop curve and NG-mRuby3 1 DPT curves from [Fig 3C](#pone.0219886.g003){ref-type="fig"} are also shown for reference. **(B)** Example fluorescence decay curves from a single cell expressing NG-mRuby3 5 DPT before and after acceptor photobleaching. The NG-Stop curve from [Fig 3C](#pone.0219886.g003){ref-type="fig"} is repeated here for reference.

(TIF)

###### 

Click here for additional data file.

###### Raw immunoblot data for [S4 Fig](#pone.0219886.s004){ref-type="supplementary-material"}.

Raw and unmodified immunoblot scans used in the construction of [S4 Fig](#pone.0219886.s004){ref-type="supplementary-material"}.

(PDF)

###### 

Click here for additional data file.

###### Amino acid sequences of constructs used in this manuscript.

The color-coded amino acid sequences for each construct are shown above. For NG-P2A-mRuby3, the cleavage site is found between the glycine and proline residues found immediately before the mRuby3 sequence and is indicated with a \|.

(TIF)

###### 

Click here for additional data file.
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1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: No

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: Manuscript PONE-D-19-18735 from Kammermeier and coworkers describes a systematic comparison of 3 different RFPs (mRuby3, mScarlet, and mCherry) as FRET acceptors for an mNeonGreen donor FP. Systematic characterization efforts such as this are an important contribution to the scientific literature since they can save other labs time, money, and effort in picking the best FRET pair to use for their own investigations. Overall, the authors achieve exactly what they set out to do in a fairly straightforward manner. In addition, the manuscript is well-written, logically organized, and the results are presented very clearly. Essentially, the authors found that mScarlet and mCherry behaved pretty much as expected, but that mRuby3 exhibits a much lower FRET efficiency than expected. This is exactly the sort of unexpected result that shows why studies such as this are important. One way that the authors could have increased the impact of this paper would have been to also evaluate mNeonGreen use EGFP as FRET donors for these applications. Given the lack of previous studies on the performance of mNeonGreen under 2P illumination, it would have been helpful to perform side-by-side 2P characterization of brightness and lifetime with EGFP. Based on this study, the authors conclude that mNeonGreen is suitable. It would have been useful to know if this means it is better, worse, or similar to EGFP.

My recommendation is that this manuscript will be suitable for publication once the following comments and minor revisions have been addressed.

Comments and concerns to be addressed

1\. The authors state that "\...histograms of the slopes for individual cell expressing the NG-Cherry and NG-Scarlet constructs revealed a reasonable distribution and narrow spread of slopes (Fig 5C,D)." While it is true that both Cherry and Scarlet are narrower than Ruby, it does appear as though mCherry has a much narrower spread than mScarlet, and this would seem to represent a desirable property in a FRET acceptor. Given this, plus the fact that mCherry gave identical quenching to mScarlet in FLIM, suggests that (at least for FLIM) mCherry might actually be the better choice. This should be pointed out in the conclusion.

2\. Most cells expressing NG-mRuby3 were observed to decrease their lifetime over the course of several days, suggesting that the low FRET efficiency observed 1 DPT was due to the slow maturation. Some cells were observed to still be exhibiting donor-only like lifetimes after 5 DPT. Perhaps a reasonable explanation for this result is cell-to-cell heterogeneity in terms of the rate of protein turnover? That is, cells that have faster turnover, and faster rate or protein synthesis, might be expected to never accumulate substantial amounts of the fully mature fusion protein, no matter how long they are cultured. One way to examine this might be to plot lifetime vs mNeonGreen fluorescence intensity. If this hypothesis is correct, brighter cells might be expected to have lower lifetimes due to slower turnover of the protein and accumulation to higher levels. In both the abstract and discussion, the authors emphasize that the reasons for the poor performance of mRuby3 are unclear. It does seem like, ultimately, it is the very slow maturation (and possibly efficiency of maturation and/or rate of protein turnover) that is the culprit. Based on the data in Table 1, that is the one characteristic in which mRuby3 is the outlier. I think that the authors could be bit more decisive in pinning the blame on this factor.

3\. The explanation that short linkers (line 487) are the reason why mCherry and mScarlet performed similarly does not make sense. The observed FRET efficiencies are all in the 20-30% range, meaning that the two fluorophores are at distances greater than the Forster radii. It is only when two fluorophores get very close that FRET efficiencies approach 100% and differences in Forster radii become irrelevant. I suspect that the two factors that really matter here are the time for protein maturation as well as the fraction of RFP proteins that make a fluorophore. I suspect that mCherry is particularly efficient at forming the chromophore, which is why it typically provides a bright signal in cells, even though its quantum yield and extinction coefficient are not as high as other proteins.

4\. I would like to suggest that the authors make it clear about the performance of these FPs for FRET (which only refers to donor quenching) and sensitized emission. For example, in the Conclusion the author's state that "\... but mScarlet-I outperformed mCherry in the intensiometric study due to its higher quantum yield." It should be clear that the better performance is due to greater sensitized emission due to the higher quantum yield. Strictly speaking, the quantum yield of the acceptor is irrelevant to FRET (but critical for sensitized emission, of course).

Minor revisions

\- To someone who is not an expert in this field, the term \'better tissue penetrance' in reference to green and red fluorophores. This should be reworded to make it clear that longer wavelengths of excitation and emission light are what better penetrate through tissue.

\- I think it is important to always include the 'm' and the '-I' in the case of mScarlet-I, when referring to the FPs. Dropping these could cause some confusion for readers.

\- Line 99: missing 'hours'

\- Line 234: its

\- Line 295: We first sought\...

Reviewer \#2: This manuscript presents a useful evaluation of three red-emitting FRET acceptors for the green FP mNeonGreen. The results are presented clearly and the work was clearly rigorous.

Suggestions:

1\. The authors should be very clear in the caveat that these measurements were done using only one configuration (N-terminal mNeonGreen, C-terminal red FPs, only one linker used), and may not be generalizable to other constructs or sensors made using these FPs. The work was also done using only one donor and three acceptors, and thus is not generalizable to any other potential FRET pairs.

2\. The presence of a second, lower MW band on Western blots is not surprising when using red-emitting FPs with a DsRed-type chromophore, which all three acceptor FPs possess. This is due to hydrolysis of the red chromophore upon protein denaturation (the acylimine moiety is vulnerable to hydrolysis), and is generally not an indicator of proteolysis. The authors may wish to revise their discussion of this observation to reflect this.

3\. Despite the fact that mRuby3 clearly does not perform well in this assay, it remains mysterious and concerning that the authors observed such extreme heterogeneity in their transfected cells even after several days of maturation time. From the description of the constructs, it seems possible that the same DNA sequence, encoding the amino acid sequence SKGEE, may appear three separate times in each construct, since all of the FPs being tested have \"GFP ends,\" i.e. the first and last seven amino acids have been altered or appended to match those of GFP (MVSKGEE\....GMDELYK). If it is indeed the case that this 15 base pair sequence is repeated three times in each construct, it is plausible that some recombination may occur after transfection. Ideally, the authors should fix this issue if it indeed exists.

Reviewer \#3: In this manuscript, McCullock et al tested mNeonGreen fused with one of three RFPs (mCherry, mRuby3, and mScarlet) for FRET efficiency in 2 assays (1p emission unmixing and 2p FLIM), finding the FRET efficiency the an mNeonGreen-mRuby3 tandem fusion was not as high as that of the mCherry or mScarlet fusion. They also investigated the variability of maturation of each fluorophore within the fusion proteins, finding that more cells showed high green and low red fluorescence or vice versa when expressing the mRuby3 fusion than when expressing the mCherry or mScarlet fusion. They also find that the FRET efficiency (measured by FLIM) improves substantially between 1 day and 2 days post transfection of the mNeonGreen-mRuby3 fusion. These last two results is indicative of inconsistent folding of mNeonGreen or of mRuby3 within the mNeonGreen-mRuby3 fusion protein.

I praise the authors for performing a comparison between mCherry, mRuby3, and mScarlet which are perhaps the three most robustly performing RFPs. The finding that mRuby3 has high variability in maturation within one particular constructs, the mNeonGreen-mRuby3 fusion, while mCherry and mScarlet do not in similar constructs, certainly raises the caveat that one cannot always assume all protein domains can tolerate fusions very well. However this study falls short of convincingly proving its conclusions for the following reasons:

1\. The conclusions of this paper are written to apply to all uses of FRET but the example chosen of a tandem fusion between acceptor and donor is actually unlike any FRET reporter (it is more conformationally restricted than any FRET reporter would be). What about a real FRET reporter such as a single-chain kinase reporter (the prototype being AKAR)? And what about bimolecular reporters such as those used extensively by Ryohei Yasuda using FLIM?

2\. Even within the confines of studying a donor-acceptor pair, only a single fusion protein (the mNeonGreen-mRuby3 protein) is being studied. It is premature to generalize or make predictions outside of this single protein.

3\. Even within the even more restricted topic of whether mNeonGreen and mRuby3 can show high FRET coupling within a tandem fusion, then some simple troubleshooting is required at a minimum. Whereas previous studies used mClover3 and mRuby3 with good results, this study has swapped mClover3 for mNeonGreen. The new fusion protein may very well not allow folding of mRuby3 as well as previous fusion proteins.

a\. For example, the mNeonGreen polypeptide may interfere with the mRuby3 polypeptide during protein folding; this might be the case either due to slower folding of mNeonGreen or specific peptide sequences within prefolded mNeonGreen binding to sequences of prefolded mRuby3. It is well known that domains of proteins can interfere with each other during folding, and natural proteins have evolved mechanisms such as translational pauses using rare codons and stiff linkers to allow domains to fold more independently.

b\. Another reason for poor folding could be in the linkers themselves. It is will known that the sequence of linkers can greatly affect the folding of proteins attached to the linkers, e.g. George and Heringa 2002, PMID 12538905, or Chen et al 2014, PMID 23026637. Proline-rich and glycine-rich linkers are less likely to themselves interfere with the folding of an attached domain. Based on the authors' description of their fusion protein, the linker between folded elements of mNeonGreen and mRuby3 has the sequence VMGMDELYKVSKEE, where the VMGMDELYK is brought in from mNeonGreen. This sequence contains a large proportion of hydrophobic and charged residues, which could interact with mRuby3 sequences to intefere with folding, and a scarcity of glycine or proline residues.

4\. The authors chose to test only mNeonGreen as a donor. However it is not that much brighter than mClover3 (QY of 80% vs 78%), and the mRuby3 used here was actually taken out of the mClover3-mRuby3 fusion which does show high FRET. It would seem that the mClover3-mRuby3 should be used as a positive control for FRET (the authors could just use the existing construct they obtained from Addgene).

5\. Likewise the authors make no comparisons between mNeonGreen and other GFPs in fluorescence lifetime or brightness or photostability in their FLIM system. It was reported that mNeonGreen is as photostable as EGFP and more photostable than mClover3 in one-photon illumination, but relative photostability in two-photon illumination is unknown. The authors have already done the characterization for mNeonGreen, so it would be useful to characterize EGFP or mClover3 for comparison.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

Reviewer \#3: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0219886.r002

Author response to Decision Letter 0

2 Jan 2020

We would like to thank the editor and reviews for taking time to critically review our manuscript and for providing a valuable constructive critique of our work. We have read their comments carefully and have attempted to integrate their feedback into our revised manuscript to the best of our ability. This included the development and evaluation of several new constructs, as well as extensive text revisions within results and discussion sections. We will begin by addressing several comments that were common among more than one reviewer before addressing each reviewer's remaining comments below.

General Comments

Reviewers \#1 and \#3 both requested that we provide lifetime and photobleaching data for a more common FP under our 2-photon imaging system to act as a reference for mNeonGreen's performance.

We agree that repeating these experiments with an addition reference protein would be beneficial, so examined EGFP's stability using the same methodology and report these findings in S2 Fig within the Supplemental Information as well as include a short discussion of the results with the results section.

Reviewer \#2 and \#3 both expressed concern over the manuscript over-generalizing our results, stressing that we are testing our fluorescent proteins (FP) under a limited number of conditions which may not be representative of all possible FRET experiment using mNeonGreen (NG) and the various red FPs in our manuscript.

We would like to thank the reviewers for pointing this out, as we certainly agree that our results may not be representative of all NG-red FP FRET. To address this, we made text edits to our manuscript where appropriate to stress that we developed and are testing a model system. Furthermore, we include a new paragraph at the end of the Discussion section to highlight the parts of our findings that may be more generalizable to other systems, while discussing how there may be unpredictable differences between our systems and others, stressing that it's important to conduct further testing within an individual's system of choice.

Reviewer \#1

1\. The authors state that "\...histograms of the slopes for individual cell expressing the NG-Cherry and NG-Scarlet constructs revealed a reasonable distribution and narrow spread of slopes (Fig 5C,D)." While it is true that both Cherry and Scarlet are narrower than Ruby, it does appear as though mCherry has a much narrower spread than mScarlet, and this would seem to represent a desirable property in a FRET acceptor. Given this, plus the fact that mCherry gave identical quenching to mScarlet in FLIM, suggests that (at least for FLIM) mCherry might actually be the better choice. This should be pointed out in the conclusion.

Initially we were cautious of our interpretation of our slope data because it is unclear if mCherry's narrower distribution was due to a higher level of expression/maturation efficiency or if its due to mCherry's lower brightness, or both. That being said, the distribution of lifetimes we received for NG-mCherry was also narrower than that of NG-mScarlet-I, so we are willing to agree that mCherry did act as a more consistent acceptor and modified the text of the conclusion to include this.

2\. Most cells expressing NG-mRuby3 were observed to decrease their lifetime over the course of several days, suggesting that the low FRET efficiency observed 1 DPT was due to the slow maturation. Some cells were observed to still be exhibiting donor-only like lifetimes after 5 DPT. Perhaps a reasonable explanation for this result is cell-to-cell heterogeneity in terms of the rate of protein turnover? That is, cells that have faster turnover, and faster rate or protein synthesis, might be expected to never accumulate substantial amounts of the fully mature fusion protein, no matter how long they are cultured. One way to examine this might be to plot lifetime vs mNeonGreen fluorescence intensity. If this hypothesis is correct, brighter cells might be expected to have lower lifetimes due to slower turnover of the protein and accumulation to higher levels. In both the abstract and discussion, the authors emphasize that the reasons for the poor performance of mRuby3 are unclear. It does seem like, ultimately, it is the very slow maturation (and possibly efficiency of maturation and/or rate of protein turnover) that is the culprit. Based on the data in Table 1, that is the one characteristic in which mRuby3 is the outlier. I think that the authors could be bit more decisive in pinning the blame on this factor.

We would like to thank the reviewer for the suggestion, as we do think it is likely that differences in protein turnover or stability from one cell to another causes the heterogeneity we observe with slow maturing acceptors (All mRuby3 constructs as well as a new mScarlet construct). Unfortunately, we are not able to conduct the suggested analysis due to our lifetime imaging methodology. While collecting lifetimes, it is important for us to keep the counts per second our detectors receive within a particular range to allow for accurate detection of lifetimes without overloading the detectors, which would cause artificial shorting of the lifetime (or damage to the detector in extreme situations). Because of this, we modulate the laser power used from field to field as necessary, which prevents us from making comparisons of cell intensity from one field to another. We did include a discussion of this idea within Discussion section though.

3\. The explanation that short linkers (line 487) are the reason why mCherry and mScarlet performed similarly does not make sense. The observed FRET efficiencies are all in the 20-30% range, meaning that the two fluorophores are at distances greater than the Forster radii. It is only when two fluorophores get very close that FRET efficiencies approach 100% and differences in Forster radii become irrelevant. I suspect that the two factors that really matter here are the time for protein maturation as well as the fraction of RFP proteins that make a fluorophore. I suspect that mCherry is particularly efficient at forming the chromophore, which is why it typically provides a bright signal in cells, even though its quantum yield and extinction coefficient are not as high as other proteins.

We would like to thank the reviewer for pointing out the error in our logic and have replaced the relevant discussion section with one suggesting this may be due to mCherry's maturation properties.

4\. I would like to suggest that the authors make it clear about the performance of these FPs for FRET (which only refers to donor quenching) and sensitized emission. For example, in the Conclusion the author's state that "\... but mScarlet-I outperformed mCherry in the intensiometric study due to its higher quantum yield." It should be clear that the better performance is due to greater sensitized emission due to the higher quantum yield. Strictly speaking, the quantum yield of the acceptor is irrelevant to FRET (but critical for sensitized emission, of course).

We have modified our conclusions to better clarify this point.

\- To someone who is not an expert in this field, the term \'better tissue penetrance' in reference to green and red fluorophores. This should be reworded to make it clear that longer wavelengths of excitation and emission light are what better penetrate through tissue.

We have added additional wording to clarify.

\- I think it is important to always include the 'm' and the '-I' in the case of mScarlet-I, when referring to the FPs. Dropping these could cause some confusion for readers.

We have modified the names of constructs throughout the paper (text and figures) to include the full names of the red FPs for clarity.

Reviewer \#2

1\. The authors should be very clear in the caveat that these measurements were done using only one configuration (N-terminal mNeonGreen, C-terminal red FPs, only one linker used), and may not be generalizable to other constructs or sensors made using these FPs. The work was also done using only one donor and three acceptors, and thus is not generalizable to any other potential FRET pairs.

Please see general comments above.

2\. The presence of a second, lower MW band on Western blots is not surprising when using red-emitting FPs with a DsRed-type chromophore, which all three acceptor FPs possess. This is due to hydrolysis of the red chromophore upon protein denaturation (the acylimine moiety is vulnerable to hydrolysis), and is generally not an indicator of proteolysis. The authors may wish to revise their discussion of this observation to reflect this.

We would like to thank the review for pointing out that the acylimine moiety is vulnerable to hydrolysis. We have updated our discussion of the western blot results (which are now mostly contained within the S4 Figure caption) to specify that we were referring to proteolysis of the linker itself, and that extra bands between monomeric mNeonGreen/mClover3 and the dimer band are due to this process.

3\. Despite the fact that mRuby3 clearly does not perform well in this assay, it remains mysterious and concerning that the authors observed such extreme heterogeneity in their transfected cells even after several days of maturation time. From the description of the constructs, it seems possible that the same DNA sequence, encoding the amino acid sequence SKGEE, may appear three separate times in each construct, since all of the FPs being tested have \"GFP ends,\" i.e. the first and last seven amino acids have been altered or appended to match those of GFP (MVSKGEE\....GMDELYK). If it is indeed the case that this 15 base pair sequence is repeated three times in each construct, it is plausible that some recombination may occur after transfection. Ideally, the authors should fix this issue if it indeed exists.

The reviewer is correct that this sequence does appear two or three times for all constructs. For clarity, we include a new supplemental table (S1 Table) to clearly disseminate the amino acid sequence of our constructs. As for recombination, we believe that it would be more likely to occur within bacteria while we were making or propagating the constructs, and we have assured that this is not happening through sanger sequencing of each construct before it was used in the mammalian cells. If recombination was to occur in the mammalian cells to a significant extent that resulted in mNeonGreen without a red protein acceptor, we should be able to detect that with western blotting, and we did not (S4 Fig). Given that data, and our confocal data which suggest that the major phenotype is mNeonGreen fluorescence without red FP fluorescence, we do not believe recombination within our HEK293 cells is a problem.

Reviewer \#3

1\. The conclusions of this paper are written to apply to all uses of FRET but the example chosen of a tandem fusion between acceptor and donor is actually unlike any FRET reporter (it is more conformationally restricted than any FRET reporter would be). What about a real FRET reporter such as a single-chain kinase reporter (the prototype being AKAR)? And what about bimolecular reporters such as those used extensively by Ryohei Yasuda using FLIM?

We hope that the information we disseminate in this manuscript will ultimately aid the development of new and exciting FRET systems of various kinds, including but not limited to biosensors. Although we are capable of testing these FPs outside of our model system, we do not believe there is a "standard" system that would enable fair comparison between the results we received with our model system and other systems, without testing each individual system. As reviewer \#2 and \#3 pointed out, the data we receive from our system is situational, but that assumption also applies to other systems as well. Given this, we do not feel like it will be an overly meaningful addition to develop and test a new set of reporters.

2\. Even within the confines of studying a donor-acceptor pair, only a single fusion protein (the mNeonGreen-mRuby3 protein) is being studied. It is premature to generalize or make predictions outside of this single protein.

During the process of revising the manuscript, we developed several new constructs which are described below.

3\. Even within the even more restricted topic of whether mNeonGreen and mRuby3 can show high FRET coupling within a tandem fusion, then some simple troubleshooting is required at a minimum. Whereas previous studies used mClover3 and mRuby3 with good results, this study has swapped mClover3 for mNeonGreen. The new fusion protein may very well not allow folding of mRuby3 as well as previous fusion proteins.

a\. For example, the mNeonGreen polypeptide may interfere with the mRuby3 polypeptide during protein folding; this might be the case either due to slower folding of mNeonGreen or specific peptide sequences within prefolded mNeonGreen binding to sequences of prefolded mRuby3. It is well known that domains of proteins can interfere with each other during folding, and natural proteins have evolved mechanisms such as translational pauses using rare codons and stiff linkers to allow domains to fold more independently.

b\. Another reason for poor folding could be in the linkers themselves. It is will known that the sequence of linkers can greatly affect the folding of proteins attached to the linkers, e.g. George and Heringa 2002, PMID 12538905, or Chen et al 2014, PMID 23026637. Proline-rich and glycine-rich linkers are less likely to themselves interfere with the folding of an attached domain. Based on the authors' description of their fusion protein, the linker between folded elements of mNeonGreen and mRuby3 has the sequence VMGMDELYKVSKEE, where the VMGMDELYK is brought in from mNeonGreen. This sequence contains a large proportion of hydrophobic and charged residues, which could interact with mRuby3 sequences to intefere with folding, and a scarcity of glycine or proline residues.

We thank the reviewer for this discussion, and we agree that simply because our model system worked well for mScarlet-I and mCherry does not mean it was necessarily a good system to evaluate mRuby3. The study that originally published mRuby3 (Bajar, et al (2016); ref \#10) evaluated its performance as an acceptor for EGPF, mClover3, and mNeonGreen, and reported excellent results with each (35%, 45%, and 48% FRET efficiencies respectively). In that study they removed the "GFP ends" (GITHGMDELYK for EGFP and mClover3) or (GMDELYK for mNeonGreen) from the donors and fused them to mRuby3 (amino acids 3-233) with the following linker sequence: LESFFEDPMVSKGEE resulting in an effective linker of about 12 amino acids. Given this, we believe it's is unlikely that an mNeonGreen which is 17 amino acids away would interfere with mRuby3 more than one that is approximately 12 amino acids away. Nonetheless, we developed two new tandems containing mRuby3: a construct with mNeonGreen fused to mRuby3's c-terminus through GGSGG linker, and a construct in which a P2A self-splicing peptide was inserted between the mNeonGreen and mRuby3. Additionally, we tested a slow maturing variant of mScarlet-I, mScarlet. The data pertaining to these constructs are found in the new Fig 6, and lead us to conclude that factors intrinsic to mRuby3 are the source of its deficiencies as an acceptor, particularly its slow maturation. As for the composition of what we consider our "17 amino acid linker" in our first tandems (NG-mRuby3 and others), we chose to maintain the "GFP ends" of the proteins because we feel these are less frequently removed then they are kept.

4\. The authors chose to test only mNeonGreen as a donor. However it is not that much brighter than mClover3 (QY of 80% vs 78%), and the mRuby3 used here was actually taken out of the mClover3-mRuby3 fusion which does show high FRET. It would seem that the mClover3-mRuby3 should be used as a positive control for FRET (the authors could just use the existing construct they obtained from Addgene).

We tested the mClover3-mRuby3 performance and report the data in S5 Fig, as well as a description of the results in the Results section. In summary, our data from this construct was more consistent our mNeonGreen donor data than what was previously reported for mClover3 as a donor (Bajar, et al (2016); ref \#10).

5\. Likewise the authors make no comparisons between mNeonGreen and other GFPs in fluorescence lifetime or brightness or photostability in their FLIM system. It was reported that mNeonGreen is as photostable as EGFP and more photostable than mClover3 in one-photon illumination, but relative photostability in two-photon illumination is unknown. The authors have already done the characterization for mNeonGreen, so it would be useful to characterize EGFP or mClover3 for comparison.

Please see general comments above.
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We look forward to receiving your revised manuscript.
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1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#3: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#3: Yes
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3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: I Don\'t Know

Reviewer \#3: Yes
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4\. Have the authors made all data underlying the findings in their manuscript fully available?
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5\. Is the manuscript presented in an intelligible fashion and written in standard English?
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Reviewer \#1: Yes
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\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)
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We again thank the editor and reviewers for their time, comments and thoughts regarding our manuscript. We have corrected typographical errors and ensured all figure references are to the correct figure, and that all references are consistently formatted to PLOS standards. The remaining points are addressed below.

Reviewer \#1: I would have liked to see the lifetime data for EGFP (Fig S2) with the data in Fig. 3ABC.

The overall goal of our work is compare various red acceptors. The specific goal of Figure 3 is to establish that mNG is a good donor for the 2-photon FLIM experiments with which we will compare various red acceptors, not that mNG is superior to other specific donors such as EGFP. Therefore, we believe the supplemental data is an appropriate place for our EGFP data as more expert or multi-photon familiar readers can refer to that section for the comparison of donors while the general reader interested in acceptor behavior can move to the next section. We would like to point out that we took care to design Figure S2 to permit ease of comparison of mNG in Figure 3 and EGFP in S2 (keeping the scaling in the case of panel A and the axes for panels C and D that same, as well as the color coding and symbols used, and significance indicators) despite the data being in two separate places in the manuscript.

Reviewer \#3: I only suggest that they now add mClover3 and mScarlet to Table 1 (\"Properties of the fluorescent proteins used in this study\")

We have added mClover3 and mScarlet to Table 1.

In addition, the slightly higher lifetime of mClover3 vs mNeonGreen would suggest it should be an equivalent (or maybe slightly better) FRET donor for mScarlet-I. The discussion states \"mNeonGreen is an ideal donor for Green/Red FRET experiments. Its yellow shifted excitation and emission spectrum allow for a high degree of overlap with red FPs while also being capable of being excited with lower energy blue light than cyan or more blue shifted green FPs.\" It might be appropriate to include mClover3 in this statement as well.

We agree with Reviewer \#3 that mClover3's published properties would also suggest it would also make a suitable donor, similar to mNeonGreen. Unfortunately for the purposes of the manuscript, we did not extensively test mClover3 ourselves, and are therefore not comfortable making conclusions regarding how it may act as a donor and in Green/Red FRET experiments.
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